
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Crew-11 astronauts undock in 1st-ever medical evacuation from the International Space Station (video) - 2
The Best Portable Applications for Emotional wellness and Prosperity - 3
One ant for $220: the new frontier of wildlife trafficking - 4
6 Fun Urban areas For Seniors To Travel - 5
‘The White Lotus’ sparked online interest in risky anxiety pills, study says
Remain Fit: Powerful Wellness and Work-out Schedules for a Better You
Paraplegic engineer becomes the first wheelchair user to blast into space
Illumina unveils dataset to speed up AI-powered drug discovery
Three arrested in Paris after attempted bomb attack outside Bank of America
Former hostage Eitan Mor on Hamas: ‘They will not give up until the last Israeli is gone'
Popular Home Rug Series For You
Becoming amazing at Systems administration: Individual and Expert Tips
The many ways that baking is winter therapy. With a delicious ending
6 Natural products High In Vitamins,Which One Do You Like to Eat













